Market Incident

Public · Developing

AI compiled from Infoway · 7 analyzed stories

Waters Reports Q3 2026 Revenue of $1.767 Billion, Adjusted EPS of $4.10

Waters reported third-quarter 2026 revenue of $1.767 billion, including $871 million in organic revenue, and adjusted diluted EPS of $4.10. GAAP net income was $81 million and GAAP diluted EPS was $0.82, reflecting acquisition-related and restructuring costs. The company raised its full-year 2026 revenue and adjusted EPS outlook.

Published:

Updated:

What happened

Waters reported third-quarter 2026 revenue of $1.767 billion and adjusted earnings of $4.10 per share. Revenue rose 9% as reported, and adjusted earnings per share rose 21%. The company raised its full-year outlook, while its CEO said AI is leading drugmakers to run more experiments and seek more lab products.

Global impact / market context

More experiments by drugmakers could increase demand for Waters’ laboratory instruments and supplies. The higher full-year outlook reflects the company’s stronger expectations, but the available facts do not show how investors reacted.

What to watch

  1. Check Waters’ next reported revenue; it will show whether the recent sales growth continued.
  2. Check the company’s full-year revenue and adjusted earnings outlook; Waters raised both, so later changes would show whether its expectations shifted.
  3. Check whether Waters again links AI use by drugmakers with more experiments and demand for lab products; this would show whether the stated source of demand remains present.

Affected assets

  • Waters Corporation

Evidence